Results 1–6 of 6

Title Date
1.

Practical Obstetrics and Gynecology-2013 New York, New York

December 5 — 7, 2013

The New York Marriott Marquis   COURSE DESCRIPTION: This course is intended for obstetrician-gynecologists, Family Medicine specialists, nurse-midwives and nurse practitioners. Topics wi...

December 2013

2.

Compounded Bioidentical Menopausal Hormone Therapy

Number 532

(Replaces No. 387, November 2007 and No. 322, November 2005)

ABSTRACT: Although improvement in long-term health is no longer an indication for menopausal hormone therapy, evidence supporting fewer adverse events in younger women, combined with its high overall...

August 2012

PDF Download
3.

Ob-Gyns Address Impact of Breast Cancer Treatments

Washington, DC -- As many women treated for breast cancer can attest, surgery, radiation, and chemotherapy treatments often affect other facets of their health. To address these problems, The America...

February 2012

4.

Makena Price Reduction Is Inadequate

Washington, DC -- Today K-V Pharmaceutical Company announced that it is reducing the cost of its drug Makena™ from $1,500 per dose to $690 per dose, clearly acknowledging the negative impact of...

April 2011

5.

ObGyns Respond to High Cost of Makena

Washington, DC -- The American College of Obstetricians and Gynecologists (The College), along with the American Academy of Pediatrics and the Society for Maternal-Fetal Medicine, is urging Ther-Rx C...

March 2011

6.

ACOG Issues Recommendations on Prevention of Blood Clots in Gynecologic Surgery Patients

Washington, DC -- Blood clots are a leading cause of disability and death in patients following surgery, despite medical advances in their prevention, diagnosis, and treatment. The American College o...

July 2007

Advertisement